PLA and PLGA microparticles for intravitreal drug delivery: An overview

Journal of Drug Delivery Science and Technology

Volumn 17, Issue 1, 2007, Pages 11-17

  Herrero Vanrell, R ^a   Molina Martinez, I T ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Controlled release; Drug delivery; Intraocular; Intravitreal; Microspheres; Poly(lactic)acid (PLA); Poly(lactic co glycolic) acid (PLGA)

Indexed keywords

ACICLOVIR; ALPHA TOCOPHEROL; CORTICOSTEROID; DEXAMETHASONE; DOXORUBICIN; DRUG ADDITIVE; FLUOROSILICONE; FLUOROURACIL; GANCICLOVIR; GELATIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; INDOMETACIN; ISOPROPYLMIRISTATE; MICROSPHERE; MYGLIOL; POLYGLACTIN; POLYLACTIC ACID; RETINOIC ACID; RETINOL; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; VASCULOTROPIN ANTIBODY;

ASEPSIS; BLINDNESS; CATARACTOGENESIS; CONTROLLED RELEASE FORMULATION; CYTOMEGALOVIRUS INFECTION; DENATURATION; DIABETIC RETINOPATHY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG SOLUBILITY; DRUG TOLERABILITY; DRUG TOLERANCE; ENDOPHTHALMITIS; GAMMA IRRADIATION; GLAUCOMA; HUMAN; KIRISAWA UVEITIS; MATHEMATICAL COMPUTING; NEUROPROTECTION; NONHUMAN; PARTICLE SIZE; PROLIFERATIVE RETINOPATHY; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA EDEMA; RETINITIS; REVIEW; SUSTAINED DRUG RELEASE; UVEITIS; VITREORETINOPATHY;

EID: 33847416281     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(07)50002-X     Document Type: Review

References (70)

1. Geroski D.H., Edelhauser H.F. - Drug Delivery for posterior segment eye disease. - Invest. Ophthalmol. Vis. Sci., 41, 961-964, 2000.
2. Velez G., Whitcup S.M. - New developments in sustained release drug delivery for the treatment of intraocular disease. - Br. J. Ophthalmol., 83, 1225-1229, 1999.
3. Herrero-Vanrell R., Refojo M.F. - Biodegradable microspheres for vitreoretinal drug delivery. - Adv Drug Deliv Rev., 52, 5-16, 2001.
4. Colthurst M.J., Williams R.L., Hiscott P.S., Grierson I. - Biomaterials used in the posterior segment of the eye. - Biomaterials, 21, 649-665, 2000.
5. Herrero-Vanrell R. - Nano y micropartículas en oftalmología. - Studium Ophthalmologicum, 16, 177-180, 1996.
6. Zimmer A., Kreuter J. - Microspheres and nanoparticles used in ocular delivery systems. - Adv. Drug Deliver. Rev., 16, 61-73, 1995.
7. Wong G.B. - Biodegradable ocular implants. - US Patent 4,997,652, 1991.
8. Herrero-Vanrell R., Refojo M.F. - Intravitreal microsphere drug delivery and method of preparation. - US Patent 5,718,922, 1998.
9. Kreuter J. - Particulates (nanoparticles and microparticles). - In: Ophthalmic Drug Delivery Systems, A.K. Mitra Ed., Marcel Dekker, New York, 1993, pp. 275-285.
10. Thomas X., Bardet L., De Bechillon I., Chemtob C., Ponchel G., Ribes M., Rozier A., Vergnaud J.P. - Nouveaux polymères à usage pharmaceutique et biomédical. Evaluation et qualification. Rapport d'une commission SFSTP. - STP Pharma Pratiques, 3, 237-252, 1993.
11. Park H., Park K. - Biocompatibility issues of implantable drug delivery systems. - Pharm. Res., 13, 1770-1776, 1996.
12. Kohm J. - Biomaterials science at a crossroad: are current product liability laws in the United States hampering innovation and the development of safer medical implants? - Pharm. Res, 13, 815-819, 1996.
13. Yasin M., Tighe B.J. - Polymers for biodegradable medical devices. - Biomaterials, 13, 9-16, 1992.
14. Yasukawa T., Kimura H., Tabata Y., Ogura Y. - Biodegradable scleral plugs for vitreoretinal drug delivery. - Adv. Drug Deliv. Rev., 16, 25-36, 2001.
15. Jaffe G.J., Pearson P.A., Ashton P. - Dexamethasone sustained drug delivery implant for the treatment of severe uveitis. - Retina, 20, 402-403, 2000.
16. Chang D.F., Garcia I.H., Hunkeler J.D., Minas T. - Phase II results of an intraocular steroid delivery system for cataract surgery. - Ophthalmology, 106, 1172-1177, 1999.
17. Hashizoe M., Ogura Y., Takanashi T., Kunou N., Honda Y., Ikada Y. - Biodegradable polymeric device for sustained intravitreal release of ganciclovir in rabbits. - Curr. Eye Res., 16, 633-639, 1997.
18. Weiner W. - New drug delivery systems for the anterior and posterior segment. - ARVO, 30 May-4 June 2006, Inv.Ophthalmol. Vis.Sci., 47, p. 112.
19. Reed A.M., Gilding D.K. - Biodegradable polymers for use in surgery. Poly(glycolic)/poly(lactic acid) homo and copolymers. 2. In vitro degradation. - Polymer, 22, 494-498, 1981.
20. Jalil R., Nixon J.R. - Biodegradable poly (lactic acid) and poly (lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. - J. Microencapsulation, 7, 297-325, 1990.
21. Conti B., Bucolo C., Giannavola C., Puglisi G., Giunchendi P., Conte U. - Biodegradable microspheres for the intravitreal administration of acyclovir: in vitro and in vivo evaluation. - Europ. J. Pharm. Sci., 5, 287-293, 1997.
22. Alonso M.J., Cohen S., Park T.G., Gupta R.K., Siber G.R., Langer R. - Determinants of release rate of tetanus vaccine from polyester microspheres. - Pharm. Res., 10, 945-953, 1993.
23. Herrero Vanrell R., Ramirez L., Fernandez-Carballido A., Refojo M.F. - Biodegradable PLGA micropheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles and sterilization process. - Pharm. Res, 16, 1323-1328, 2000.
24. Miyamoto K., Refojo M.F., Tolentino F.I., Fournier G.A., Albert D.M. - Fluorinated oils as experimental vitreous substitutes. - Arch. Ophthalmol., 104, 1053-1056, 1986.
25. Barcia E., Herradon C., Herrero-Vanrell R. - Biodegradable additives modulate ganciclovir release rate from PLGA microspheres destined to intraocular administration. - Letters in Drug Design & Discovery, 2, 148-149, 2005.
26. Herrero-Vanrell R., Herradon C., Ramirez L., Refojo M.F. - Biodegradable microspheres loaded with gancyclovir. Influence of tocopherol acetate on drug release. - ARVO, 30 May-4 June 1997, Invest. Ophthalmol. Vis. Sci., 38, p. 147.
27. Zhu Q., Herrero-Vanrell R., Herradón C., Pavan-Langston D., Refojo M.F. - Anti HCMV activity in vitro of microspheres loaded with ganciclovir dispersed on Vit E acetate. - ARVO, 31May-5 June 1998, Invest. Ophthalmol. Vis. Sci., 39, p. 11.
28. Martinez-Sancho C., Herrero-Vanrell R., Negro S. - Poly (D,L-lactide-co-glycolide) microspheres for long-term intravitreal delivery of aciclovir : influence of fatty and non-fatty additives. - J Microencapsulation, 20, 799-810, 2003.
29. Martinez-Sancho C., Herrero-Vanrell R., Negro S. - Optimisation of aciclovir poly(D,L-lactide-co-glycolide)microspheres for intravitreal administration using a factorial design study. - Int.J. Pharm., 273, 45-56, 2004.
30. Jeong J.I., Song J.G., Kang S.S., Ryu H.H., Lee Y.H., Choil C., Shin B.A., Kim K.K., Ahn K.Y., Yung S. - Preparation of poly (DL-lactide-co- glycolide) microspheres encapsulating all-trans retinoic acid. - Int.J. Pharm., 259, 79-91, 2003.
31. Martinez-Sancho C., Herrero-Vanrell R., Negro S. - Vitamin A palmitate and aciclovir biodegradable microspheres for intraocular sustained release. - Int.J. Pharm., 326, 100-106, 2006.
32. Berkland C., King M., Cox A., Kim K., Pack D.W. - Precise control of PLGA microspheres size provides enhanced control of drug release rate. - J. Control. Release, 82, 137-147, 2002.
33. Siepmann J., Faisant N., Akiki J.J., Richard J., Benoit J.P. - Effect of the size of biodegradable microparticles on drug release: experiment and theory. - J. Control. Release, 96, 123-134, 2004.
34. Tice TR., Gilley R.M. - Preparation of injectable controlled-release microcapsules by solvent evaporation process. - J. Control. Release, 2, 343-352, 1985.
35. Yasukawa T., Ogura Y., Tabata Y., Limura H., Wiedemann P., Honda Y. - Drug delivery systems for vitreoretinal diseases. - Prog. Retin. Eye Res., 23, 253-281, 2004.
36. Khoobehi B., Stradtmann M.O., Peyman G.A., Maly O. - Clearance of sodium fluorescein incorporated into microspheres from the vitreous after intravitreal injection. - Ophthalmic Surg., 22, 175-180, 1991.
37. Giordano G., Chevez-Barrios P., Refojo M.F., García C.A. - Biodegradation and tissue reaction to intravitreal biodegradable (D,L-lactic-co-glycolic)acid microspheres. - Curr. Eye Res., 14, 761-768, 1995.
38. Conte U., Giunched P.I., Puglisi, G., Giannavola C., Bucolo C., Conti B. - Biodegradable microspheres for the intravitreal administration of acyclovir: in vitro/in vivo evaluation. - Eur. J. Pharm. Sci., 5, 287-293, 1997.
39. Montera T., Ogura Y., Yoshimura N., Wada R., Hyon S.H., Ikada I. - Biodegradable microspheres containing adriamycin in the treatment of proliferative vitreoretinopathy. - Invest Ophthalmol Vis Sci., 33, 3125-3130, 1992.
40. Montera T., Ogura Y., Honda Y., Wasa R., Hyon S.H., Ikada Y. - Microspheres of biodegradable polymers as a drug-delivery system in the vitreous. - Invest Ophthalmol. Vis. Sci., 32, 1785-1790, 1991.
41. Veloso A.A.A., Zhu Q., Herrero-Vanrell R., Refojo M.F. - Ganciclovir loaded polymer microspheres in rabbit eyes inoculated with human cytomegalovirus. - Invest. Ophthalmol. Vis. Sci., 38, 665-675, 1997.
42. Ogura Y., Kimura H. - Biodegradable polymer microspheres for targeted drug delivery to the retinal pigment epithelium. - Surv. Ophthalmol., 39, S17, 1995.
43. Martinez-Sancho C., Herrero-Vanrell R., Negro S. - Study of gamma irradiation effects on aciclovir poly(D,L-lactic-co-glycolic)acid microspheres for intravitreal administration. - J. Control. Release, 99, 41-52, 2004.
44. U.K. Panel on Gamma and Electron Irradiation. - Letter to the Editor: Radiation sterilization dose, The position of the U.K. Panel on Gamma and Electron Irradiation. - Radiat. Phys. Chem., 29, 87, 1987.
45. Bittner B., Mäder K., Kroll C., bochert J.H., Kissel T. - Tetracycline HCl-loaded poly (DL-lactide-co-glycolide) microspheres prepared by spray drying technique: Influence of γ-radiation on radical formation and polymer degradation. - J. Control Release, 59, 23-32, 1999.
46. Hausberger A.G., Kenley R.A., De Luca P.P. - Gamma radiation effects on molecular weight and in vitro degradation of poly(D,L-lactide-glycolide) microparticles. - Pharm. Res., 12, 851-856, 1995.
47. Merkli A., Heller J., Tabatabay C., Gurny R. - Gamma sterilization of a semisolid (ortho ester) designed for controlled drug delivery-validation and radiation effects. - Pharm. Res., 11, 1485-1491, 1994.
48. Fernández-Carballido A., Puebla P., Herrero-Vanrell R., Pastoriza P. - Radiosterilisation of indomethacin PLGA/PEG-derivative microspheres; protective effects of low temperature during gamma-irradiation. - Int J. Pharm., 26, 129-135, 2006.
49. 2. - Pharm. Res., 15, 889-895, 1998.
50. Tsong Y., Hammestrom T., Pradeep S., Vinod P.S. - Statistical assessment of mean differences between two dissolution data sets. - Drug Inf. J., 30, 1105-112, 1996.
51. Ichan I.M., Tolentino F.I., Refojo M.F., Fournier G., Albert D.M. - Vitreous substitute. - Retina, 4, 51-59, 1984.
52. Tolentino I.F., Cajita V.N., Refojo M.F. - Vitreous injections: when to do them and why?-In: Ophthalmology Annual, R.D. Reinecke Ed., Raven Press, New York, 1989, pp. 337-348.
53. Herrero-Vanrell R., Díez A., Barcia E., Alvarez C., López I., Calonge M. - Intravitreal injection of PLGA microspheres loaded with dexamethasone in a rabbit model of panuveitis, short- and long-term efficacy. - Invest. Ophthalmol. Vis. Sci., submitted for publication.
54. Visscher G.E., Robinson R.L., Maulding H.V., Fong J.W., Pearson J.E., Argentieri G.J. - Biodegradation of and tissue reaction to 50:50 poly (DL-lactide-co-glycolide) microcapsules. - J. Biomed. Mater. Res., 19, 349, 1985.
55. Alleman E., Gurny R., Doelker E. - Drug -loaded nanoparticles. preparation methods and drug targeting issues. - Eur. J. Pharm. Biopharm., 39, 173, 1993.
56. Pastor J.C. - Proliferative vitreoretinopathy: an overview. - Survey Ophthalmology, 43, 3-18, 1998.
57. Peyman G.A., Conway M., Khoobehi B., Soike K., Niesman M.R. - Clearance of microsphere-entrapped 5-fluorouracil and cytosine arabinoside from the vitreous of primates. - Invest. Ophthalmol.Vis. Sci., 31, 109-113, 1990.
58. Giordano G.G., Refojo M.F., Arroyo M.H.-Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR. - Invest. Ophthalmol. Vis. Sci., 34, 2743-2751, 1993.
59. Van Wijngaarden P., Coster D.J., Williams K.A. - Inhibitors of ocular neovascularization: promises and potential problems. - JAMA , 293, 1509-1513, 2005.
60. Gomes Dos Santos A.L., Bochot A., Fattal E. - Intraocular delivery of oligonucleotides. - Curr. Pharm. Biotechnol., 6, 7-15, 2005
61. Rodríguez A., Calonge M., Pedroza-Seres M., Acova J.A., Messmer E.M., D'Amico D.J., Foster C.S. - Referral patterns of uveitis in a tertiary eye care center. - Arch. Ophthalmol., 114, 593-599, 1996.
62. Smith J.R. - Management of uveitis. - Clin. Ex. Med., 4, 21-29, 2004.
63. Gaudio P.A. - A review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammation. - Ocul. Immunol. Inflamm., 12, 169-192, 2004.
64. Kwak H.W., D'Amico D.U. - Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection. - Arch. Ophthalmol., 110, 259-266, 1992.
65. Herrero-Vanrell R., Alvarez Santiago C., Barcia E. - Biodegradable microspheres loaded with dexamethasone for intravitreal administration.- Invest. Ophthalmol. Vis. Sci., 40, S84, 1999.
66. Cardillo J.A., Paganelli F., Costa R.A., Silva A.A., Oliveira A.G., Lima-Filho A.A.S., Farah M.E., Belofor R., Kuppermann B.D. - Intravitreal bioerudivel sustained-release triamcinolone micropsheres systems (RETAAC): safety and pharmacokinetic in the rabbit eye and a preliminary report of its potential usefulness for the treatment of diabetic macular edema. - ARVO, Fort Lauderdale (FL), 30 May-4 June 2006, Inv. Ophthalmol. Vis. Sci., 47, p. 183.
67. Chowdhury D.K., Mitra A.K. - Kinetics of a model nucleoside (guanosine) release from biodegradable poly(DL-lactide-co-glycolide)microspheres: a delivery system for long-term intraocular delivery. - Pharm. Dev. Technol., 5, 279-285, 2000.
68. Jab D.A., Enger C., Barlett J.B. - Cytomegalovirus retinits and acquired immunodeficiency syndrome. - Arch. Ophthalmol., 107, 75-80, 1989.
69. Henry K., Cantrill H., Fletcher C., Chinnock B.J., Balfour H.H. - Use of intravitreal ganciclovir (dihydroxy propoxy methylguanine) for cytomegalovirus retinitis in a patient with AIDS. - Am. J. Ophthalmol., 103, 17-23, 1987.
70. Young M. - Role of nanotechnology in retinal repair. - ARVO, Fort Lauderdale (FL), 30 May-4 June, Inv. Ophtahlmol. Vis. Sci., 47, 2006, p. 53.